{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:27:54Z","timestamp":1791822474955,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81371876"],"award-info":[{"award-number":["No.81371876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Research Center for Child Health and Disorders General Project","award":["NCRCCHD-2019-GP-04"],"award-info":[{"award-number":["NCRCCHD-2019-GP-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12072-020-10021-5","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T15:02:41Z","timestamp":1582642961000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Yuting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4550-9436","authenticated-orcid":false,"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"issue":"2","key":"10021_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cld.2016.12.004","volume":"21","author":"I Vodkin","year":"2017","unstructured":"Vodkin I, Kuo A. Extended criteria donors in liver transplantation. Clin Liver Dis 2017;21(2):289\u2013301","journal-title":"Clin Liver Dis"},{"key":"10021_CR2","doi-asserted-by":"crossref","unstructured":"Chang MS, Olsen SK, Pichardo EM, et al. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience. Transplantation 2013;95(7):960\u2013965","DOI":"10.1097\/TP.0b013e3182845f97"},{"issue":"4","key":"10021_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","volume":"6","author":"S Feng","year":"2006","unstructured":"Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6(4):783\u2013790","journal-title":"Am J Transplant"},{"issue":"2","key":"10021_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","volume":"52","author":"E Cholongitas","year":"2010","unstructured":"Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010;52(2):272\u2013279","journal-title":"J Hepatol"},{"issue":"3","key":"10021_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.21998","volume":"16","author":"S Saab","year":"2010","unstructured":"Saab S, Waterman B, Chi AC, et al. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transpl 2010;16(3):300\u2013307","journal-title":"Liver Transpl"},{"issue":"2","key":"10021_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-6143.2012.04315.x","volume":"13","author":"E Cholongitas","year":"2013","unstructured":"Cholongitas E, Papatheodoridis GV. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. Am J Transplant 2013;13(2):353\u2013362","journal-title":"Am J Transplant"},{"key":"10021_CR7","doi-asserted-by":"crossref","unstructured":"Skagen CL, Jou JH, Said A. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts\u2014a systematic analysis. Clin Transplant 2011;25(3):E243\u2013E249","DOI":"10.1111\/j.1399-0012.2011.01409.x"},{"issue":"5","key":"10021_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/ajt.13187","volume":"15","author":"S Huprikar","year":"2015","unstructured":"Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 2015;15(5):1162\u20131172","journal-title":"Am J Transplant"},{"key":"10021_CR9","unstructured":"Chinese Society of Organ Transplantation, Chinese Medical Association, Chinese Society of Hepatology. The practice of guideline on prophylaxis and treatment of hepatitis B for liver transplantation in China (2016 edition). Zhonghua Gan Zang Bing Za Zhi 2016;24:885\u2013891"},{"issue":"9959","key":"10021_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet 2014;384(9959):2053\u20132063","journal-title":"Lancet"},{"issue":"2","key":"10021_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.29082","volume":"66","author":"S Paul","year":"2017","unstructured":"Paul S, Dickstein A, Saxena A, et al. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis. Hepatology 2017;66(2):379\u2013388","journal-title":"Hepatology"},{"issue":"20","key":"10021_CR12","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25(20):3443\u20133457","journal-title":"Stat Med"},{"key":"10021_CR13","unstructured":"Higgins JPT Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions (version 5.1.0). The Cochrane Collaboration; 2011. www.cochrane-handbook.org. Accessed 15 Aug 2016"},{"issue":"10","key":"10021_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/lt.24814","volume":"3","author":"SH Wang","year":"2017","unstructured":"Wang SH, Loh PY, Lin TL, et al. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft. Liver Transpl 2017;3(10):1266\u20131272","journal-title":"Liver Transpl"},{"issue":"39","key":"10021_CR15","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.3748\/wjg.v21.i39.11112","volume":"21","author":"CC Lin","year":"2015","unstructured":"Lin CC, Yong CC, Chen CL. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation. World J Gastroenterol 2015;21(39):11112\u201311117","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10021_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00535-010-0313-6","volume":"46","author":"M Ishigami","year":"2011","unstructured":"Ishigami M, Kamei H, Nakamura T, et al. Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts. J Gastroenterol 2011;46(3):367\u2013377","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"10021_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jvh.13164","volume":"26","author":"BW Duan","year":"2019","unstructured":"Duan BW, Tian LT, Lin DD, et al. Long-term consequences of stopping HBIG and\/or nucleotide analogues in liver transplant recipients administered hepatitis B vaccination to prevent HBV reinfection. J Viral Hepat 2019;26(Suppl 1):85\u201389","journal-title":"J Viral Hepat"},{"issue":"4","key":"10021_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jvh.12818","volume":"25","author":"X Yue","year":"2018","unstructured":"Yue X, Ge C, Zhuge S, et al. Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: a hospital-based study. J Viral Hepat 2018;25(4):373\u2013380","journal-title":"J Viral Hepat"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-020-10021-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:46:03Z","timestamp":1614127563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-020-10021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10021"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10021-5","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"20 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yuting Yang, Ailong Huang, and Yao Zhao have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}